Health Care: Drugs

Alexza Pharmaceuticals Inc (ALXA: NASDAQ)

$2.27 n/a | n/a%
10/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.27
52 Week High 5.93
52 Week Low 1.99
Avg. Daily Vol. (Mil) 0.14
Beta (3 year) 1.99
Share Related Items
Mkt Cap (Mil) 39.43
Shares Out (Mil) 17.37
Float (Mil) 17.03
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.60
Current Ratio 5.30
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.53
Price/Book 0.00
Price/Cash Flow -1.30
Per Share Data
Earnings -2.00
Sales 0.41
Book Value 0.00
Cash Flow -1.70
Business Summary
Alexza Pharmaceuticals, Inc. is a pharmaceutical company engaged in the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. ADASUVE is its only approved product.
General Information
2091 Stierlin Court
Mountain View, CA 94043
www.alexza.com
Industry : Drugs
Sector: Health Care
Employees: 90
CEO: Thomas B. King
Short Interest
Current Month (Mil) 1.32
Previous Month (Mil) 1.36
Short Interest Ratio (Days) 11.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -45.60
Return on Investments -130.70
Profitability
Gross Margin -63.30
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ALXA

Latest ALXA Headlines from TheStreet

More Financial News for ALXA

Press Releases for ALXA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter